| HCVTX | JFLJX | HCVTX / JFLJX | |
| Total Expense Ratio | 0.75 | 0.43 | 174% |
| Annual Report Gross Expense Ratio | 0.75 | 0.43 | 174% |
| Fund Existence | 20 years | 9 years | - |
| Gain YTD | 3.950 | 2.989 | 132% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 15000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 140M | 4.36B | 3% |
| Annual Yield % from dividends | 3.37 | 3.70 | 91% |
| Returns for 1 year | 9.22 | 6.62 | 139% |
| Returns for 3 years | 30.40 | 23.90 | 127% |
| Returns for 5 years | 16.32 | 11.33 | 144% |
| Returns for 10 years | 60.86 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ODVIX | 39.97 | 0.70 | +1.78% |
| Invesco Developing Markets R6 | |||
| AXVIX | 22.21 | -0.04 | -0.18% |
| Acclivity Small Cap Value I | |||
| ATGDX | 13.95 | -0.09 | -0.64% |
| American Century International Gr R6 | |||
| ERHSX | 14.60 | -0.17 | -1.15% |
| Eaton Vance Worldwide Health Sci R | |||
| MSSMX | 10.76 | -0.13 | -1.19% |
| Morgan Stanley Inst Inception A | |||